These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3936345)
1. The antiinflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid). Gilman SC; Carlson RP; Chang J; Lewis AJ Agents Actions; 1985 Oct; 17(1):53-9. PubMed ID: 3936345 [TBL] [Abstract][Full Text] [Related]
2. The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects. Carlson RP; Datko LJ; Chang J; Nielsen ST; Lewis AJ Agents Actions; 1984 Jun; 14(5-6):654-61. PubMed ID: 6433676 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory activity of Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid). Gilman SC; Carlson RP; Lewis AJ J Immunopharmacol; 1985; 7(1):79-98. PubMed ID: 3874243 [TBL] [Abstract][Full Text] [Related]
4. Immunological abnormalities in rats with adjuvant-induced arthritis--II. Effect of antiarthritic therapy on immune function in relation to disease development. Gilman SC; Carlson RP; Daniels JF; Datko L; Berner PR; Chang J; Lewis AJ Int J Immunopharmacol; 1987; 9(1):9-16. PubMed ID: 3495501 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid. Carlson RP; Datko LJ; O'Neill-Davis L; Lewis AJ J Immunopharmacol; 1986; 8(2):205-21. PubMed ID: 3487593 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of the antiinflammatory activity of fentiazac and its major metabolite, p-hydroxy fentiazac. Chang J; Carlson RP; Lewis AJ Agents Actions; 1984 Oct; 15(3-4):443-7. PubMed ID: 6441470 [TBL] [Abstract][Full Text] [Related]
7. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. Cashin CH; Dawson W; Kitchen EA J Pharm Pharmacol; 1977 Jun; 29(6):330-6. PubMed ID: 18568 [TBL] [Abstract][Full Text] [Related]
8. Effects of Wy-18,251 (3-p-chlorophenyl)thiazolo[3,2-a]benzimidazole- 2-acetic acid), levamisole and indomethacin on the generation of murine T suppressor cells in vitro. Rogers CM; Rogers TJ; Gilman SC J Immunopharmacol; 1985; 7(4):479-88. PubMed ID: 2935580 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulating activity of 3-(p-chlorophenyl)thiazolo-[3,2-a] benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) in mice implanted with Lewis lung tumor. Effect of Wy-18,251 on lymphocyte proliferation and phagocytosis. Fenichel RL; Dheer SK; Grant NH; Scott DP; Bloom R; Gregory FJ J Immunopharmacol; 1983; 5(4):333-40. PubMed ID: 6607960 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo (3,2-A)-Benzimidazole-2-acetic acid (WY-13,876). Fenichel RL; Gregory FJ; Alburn HE Br J Cancer; 1976 Mar; 33(3):329-35. PubMed ID: 1083737 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism. Hanna N; Marshall PJ; Newton J; Schwartz L; Kirsh R; Dimartino MJ; Adams J; Bender P; Griswold DE Drugs Exp Clin Res; 1990; 16(4):137-47. PubMed ID: 2127565 [TBL] [Abstract][Full Text] [Related]
13. The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Wiesenberg-Boettcher I; Schweizer A; Green JR; Mueller K; Maerki F; Pfeilschifter J Drugs Exp Clin Res; 1989; 15(11-12):501-9. PubMed ID: 2517780 [TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory potency of dehydrocurdione, a zedoary-derived sesquiterpene. Yoshioka T; Fujii E; Endo M; Wada K; Tokunaga Y; Shiba N; Hohsho H; Shibuya H; Muraki T Inflamm Res; 1998 Dec; 47(12):476-81. PubMed ID: 9892041 [TBL] [Abstract][Full Text] [Related]
15. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity. Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiinflammatory activity of [(cycloalkylmethyl)phenyl]acetic acids and related compounds. Terada A; Naruto S; Wachi K; Tanaka S; Iizuka Y; Misaka E J Med Chem; 1984 Feb; 27(2):212-6. PubMed ID: 6607354 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models. Antonisamy P; Duraipandiyan V; Ignacimuthu S J Pharm Pharmacol; 2011 Aug; 63(8):1070-7. PubMed ID: 21718291 [TBL] [Abstract][Full Text] [Related]
18. [Anti-inflammatory, analgesic and antipyretic activities of alpha-(p-thenoylphenyl)-propionic acid (TN-762) (author's transl)]. Fujimura H; Tsurumi K; Hasegawa J; Yanagihara M; Hiramatsu Y; Maekawa K Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):123-36. PubMed ID: 6979498 [TBL] [Abstract][Full Text] [Related]
19. A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats. Böttcher I; Schweizer A; Glatt M; Werner H Drugs Exp Clin Res; 1987; 13(5):237-45. PubMed ID: 3500026 [TBL] [Abstract][Full Text] [Related]